FEATURED BLOGS
Dr. Tara Rajendran honors two women who, through their kindness and thoughtful attention, shaped her professional path from an early age.
"We all need to stay informed and engaged on the topic of AI in order to be the best advocates for ourselves, our profession, and our patients."
Millions of people have been affected by the war in Sudan, and the outlook for patients with cancer is particularly dire. Dr. Nabeeha Karadawi, Dr. Salma Awad Elkareem Ali Mohamed, and Nagham Ali outline the current situation and call for immediate international aid.
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
"It takes courage to see people whom you have treated lose their lives when the disease takes the upper hand," writes Dr. Pesona Grace Lucksom.
At a time when we are being asked, in every aspect of our work, to do more with less, we can expect streamlined, efficient, pragmatically designed clinical trials to play an increasingly important role in our research enterprise.
Dr. Narjust Florez, Dr. Fatima Wilder, Lauren Kiel, and Rebekah Kaufman underscore the need to comprehensively understand and address the unmet needs of young patients with lung cancer.
Dr. Joseph Merchant introduces the CPT process and recognizes ASCO colleagues who have represented the interests of members on this issue.
HemOncFellows Network organized an online discussion to address the common questions that hematology-oncology fellowship applicants have after submitting their fellowship application.
"Oncologists and APPs working together have the opportunity to increase practice volume, improve access to care, and ensure continuity for the patient," said Whitney Pritham.
It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center.
Camille Petraitis and Christine Schlemmer discuss how the roles and responsibilities of APPs in care teams vary based on the practice setting, with an emphasis on inpatient roles and focused on a dedicated inpatient medical oncology role at a nonprofit hospital.
Severe pain can lead one to places that are uncharted, unfamiliar, and unknown.
Dr. Biplov Adhikari shares how the ability for patients to continue their normal lives from within the walls of a hospital room is profoundly empowering.
Caregiver support is fragmented and inadequate. Here are 7 steps oncology professionals can take to address this urgent need.
Following the ASCO Annual Meeting, the conversations in the news, on social media, and in the hallways of our institutions tend to be dominated by advances in the field—promising new treatments, genetic targets unlocked, gains in overall survival.
Dr. Paula Isabel G. Franco participated in the ASCO IDEA program to build a community and support her goal of ending the fear of cancer in her home country.

Advertisement

Latest Comments & Discussions


Jeff Porter Sharman, MD
Nov 28, 2023
After 10 years in practice, I took the high stakes 10 year recertification exam that I paid for.  I was disappointed to find out that...

William Bruce
Nov 23, 2023
Hi, My name is william bruce, thanks for sharing this nformation. I'm truly inspired by the dedication and expertise of oncologists....

Ahmed M. Elzawawy, MD, PhD
Jul 12, 2023
Dear Dr. Lynn M. Schuchter our President of ASCO and all colleagues the members of ASCO ,  Please read this message entitled...

Ahmed M. Elzawawy, MD, PhD
Jul 12, 2023
Topic: There is a great need for game changing in global oncology Dear our President of ASCO, A few months ago , I was reading...

Most Read

Dr. Tara Rajendran honors two women who, through their kindness and thoughtful attention, shaped her professional path from an early age.
Artificial intelligence (AI) is poised to transform cancer care delivery from diagnosis to treatment selection, and even the communication between physicians and patients.
Dr. Narjust Florez, Dr. Fatima Wilder, Lauren Kiel, and Rebekah Kaufman underscore the need to comprehensively understand and address the unmet needs of young patients with lung cancer.
If we believe that dietary supplements are active compounds—and many are—then we should deal with them as medications and advise our patients accordingly.
"It takes courage to see people whom you have treated lose their lives when the disease takes the upper hand," writes Dr. Pesona Grace Lucksom.